Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A

BSX.PRA

Market cap $973M

BSX.PRA Hedge Fund Activity: Q1 2023 in Review

56 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) for Q1 2023, worth a combined $1.15B — up 3.6% from $1.11B a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BSX.PRA and 3 opened new positions — a net loss of 1 holder — while 24 trimmed existing stakes and 12 added.

The largest buyer was Bank of Montreal, opening a new position worth an estimated $27.2M. The largest seller was VOYA Investment Management, cutting an estimated $59.8M.

• 56 institutional investors held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) as of Q1 2023, down from 57 in Q4 2022.
• Funds reported $1.15B of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A stock for Q1 2023, up 3.6% quarter-over-quarter.
• 3 funds opened new Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A positions in Q1 2023 and 4 closed out, a net change of -1 holder.
• The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A buyer in Q1 2023 was Bank of Montreal, an estimated $27.2M added.
• The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A seller in Q1 2023 was VOYA Investment Management, an estimated $59.8M sold.

Based on aggregated 13F filings for Q1 2023.